News & Insights Search

Welcome to the December issue of RF Quarterly, featuring a selection of articles adapted from presentations at the 2025 RAPS Convergence in Pittsburgh, PA, on 7-9 October. The articles cover global regulatory pathways for orphan medical devices, best practices for effective collaboration around companion diagnostics, e-labeling in drugs and medical devices, and artificial intelligence (AI) in the regulatory setting – specifically, the use of generative AI (gen AI) for scaling up regulatory operations , and survey findings on how regulatory functions are adopting AI

Welcome to the September issue of RF Quarterly, focusing on global regulatory harmonization and including articles on early experiences in implementing version 4 of the electronic common technical document (eCTD v4.0); regulatory reliance in optimizing resources and accelerating patient access to therapies; and harmonization efforts in the medical device setting, specifically, quality standards, postmarket surveillance (PMS), and the role of global organizations in facilitating harmonization.

Welcome to the June issue of RF Quarterly, which focuses on regulatory writing and includes articles on a clinical overview case study and key takeaways, generative AI in regulatory writing, considerations in writing for a regulatory audience, and using process infographics for streamlining regulatory document development.

Welcome to the March issue of RF Quarterly, which focuses on regulatory project management and includes articles on the biotech asset journey (from early development to market-ready success), the transition from bench science to project management, the RPM's role in the alliance setting, and tools and techniques for regulatory project management.

Welcome to the December issue of RF Quarterly, with selected presentations from RAPS Convergence 2024 adapted as articles focusing on eSTAR best practices, regulatory challenges for medtech start-ups, product quality review of biologics and biosimilars, navigating an IND clinical hold, human factors development, the regulatory-marketing partnership, and concurrent regulatory submissions.

Welcome to the September issue of RF Quarterly, which includes articles examining artificial intelligence (AI) in medical devices, focusing on the global regulatory landscape, contact-free AI devices in clinical trials, AI-driven strategies for regulatory compliance medical devices, the role of data in AI governance, and machine learning (ML) best practices. As always, we hope the articles will provide guidance and resources for regional and global regulatory professionals. We thank the authors for their time and generosity in sharing their expertise and real-world knowledge and experience with the RAPS community.